Literature DB >> 23295472

The effect of low-frequency TENS in the treatment of neuropathic pain in patients with spinal cord injury.

E C Celik1, B Erhan, B Gunduz, E Lakse.   

Abstract

STUDY
DESIGN: Prospective, randomized and controlled study.
OBJECTIVES: The aim of the study was to investigate the effect of low-frequency transcutaneous electrical nerve stimulation (LF-TENS) in the treatment of neuropathic pain in patients with spinal cord injury (SCI).
METHODS: A total of 33 SCI patients with neuropathic pain were included in the study. History, duration, localization and characteristics of pain were recorded. Visual analog scale (VAS) was used to investigate the effect of LF-TENS four times during the day. Patients were randomly assigned to study and control groups. The study group was treated with 30 min of LF-TENS daily for 10 days while the placebo group with 30 min of sham TENS.
RESULTS: The mean age of the patients was 36.55±10.36 years. Out of 33 patients, 7 were tetraplegic and 26 were paraplegic. Twenty-three patients had complete SCI while 10 patients had incomplete injuries. Two groups were similar with respect to age, gender, duration, level and severity of injury. In the LF-TENS treatment group, a statistically significant reduction of the VAS values was observed, however, such an effect was not evident in the control group.
CONCLUSION: This study revealed that in treatment of neuropathic pain of SCI patients, LF-TENS may be effective. PERSPECTIVE: This article presents LF-TENS may effectively complement pharmacological treatment in patients with SCI and neuropathic pain.

Entities:  

Mesh:

Year:  2013        PMID: 23295472     DOI: 10.1038/sc.2012.159

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  20 in total

Review 1.  Using TENS for pain control: the state of the evidence.

Authors:  Carol G T Vance; Dana L Dailey; Barbara A Rakel; Kathleen A Sluka
Journal:  Pain Manag       Date:  2014-05

2.  Are the persistent effects of "gate control" stimulation on nociception a form of generalization of habituation that is endocannabinoid-dependent?

Authors:  Alex Hanson; Brian D Burrell
Journal:  Neurobiol Learn Mem       Date:  2018-09-06       Impact factor: 2.877

Review 3.  [Pain in patients with paraplegia].

Authors:  G Landmann; E-C Chang; W Dumat; A Lutz; R Müller; A Scheel-Sailer; K Schwerzmann; N Sigajew; A Ljutow
Journal:  Schmerz       Date:  2017-10       Impact factor: 1.107

Review 4.  Transcutaneous electrical nerve stimulation for acute pain.

Authors:  Mark I Johnson; Carole A Paley; Tracey E Howe; Kathleen A Sluka
Journal:  Cochrane Database Syst Rev       Date:  2015-06-15

Review 5.  Characterising the Features of 381 Clinical Studies Evaluating Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Relief: A Secondary Analysis of the Meta-TENS Study to Improve Future Research.

Authors:  Mark I Johnson; Carole A Paley; Priscilla G Wittkopf; Matthew R Mulvey; Gareth Jones
Journal:  Medicina (Kaunas)       Date:  2022-06-14       Impact factor: 2.948

Review 6.  Noninvasive neuromodulation and rehabilitation to promote functional restoration in persons with spinal cord injury.

Authors:  Jennifer A Iddings; Anastasia Zarkou; Edelle C Field-Fote
Journal:  Curr Opin Neurol       Date:  2021-12-01       Impact factor: 6.283

Review 7.  The effectiveness of 22 commonly administered physiotherapy interventions for people with spinal cord injury: a systematic review.

Authors:  L A Harvey; J V Glinsky; J L Bowden
Journal:  Spinal Cord       Date:  2016-06-28       Impact factor: 2.772

8.  Effect of intermittent normobaric hyperoxia for treatment of neuropathic pain in Chinese patients with spinal cord injury.

Authors:  Y Gui; H Li; M Zhao; Q Yang; X Kuang
Journal:  Spinal Cord       Date:  2014-10-07       Impact factor: 2.772

9.  The CanPain SCI clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord injury: 2021 update.

Authors:  Eldon Loh; Magdalena Mirkowski; Alexandria Roa Agudelo; David J Allison; Brooke Benton; Thomas N Bryce; Sara Guilcher; Tara Jeji; Anna Kras-Dupuis; Denise Kreutzwiser; Oda Lanizi; Gary Lee-Tai-Fuy; James W Middleton; Dwight E Moulin; Colleen O'Connell; Steve Orenczuk; Patrick Potter; Christine Short; Robert Teasell; Andrea Townson; Eva Widerström-Noga; Dalton L Wolfe; Nancy Xia; Swati Mehta
Journal:  Spinal Cord       Date:  2022-02-05       Impact factor: 2.473

10.  Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA‑21‑mediated PTEN/AKT/mTOR pathway.

Authors:  Tianyu Sun; Liying Duan; Jiaju Li; Hongyu Guo; Mingyue Xiong
Journal:  Int J Mol Med       Date:  2021-06-16       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.